acetic acid has been researched along with Inflammatory Bowel Diseases in 33 studies
Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
acetic acid : A simple monocarboxylic acid containing two carbons.
Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Juglone exhibited anti-inflammatory and antioxidant effects in the experimental colitis model and could be a therapeutic candidate for IBD." | 8.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| " The oral administration of HA-BUD-ES-NPs in an acetic acid induced colitis rat model significantly mitigated the symptoms of IBD, and improved BUD therapeutic efficacy compared to drug suspension." | 8.31 | Targeted delivery of budesonide in acetic acid induced colitis: impact on miR-21 and E-cadherin expression. ( Allam, EA; El-Kamel, AH; El-Moslemany, RM; Elkafrawy, H; Seoudi, SS, 2023) |
| " This study evaluated the anti-inflammatory effects of licofelone on acetic acid-induced colitis in rats." | 8.31 | Licofelone Attenuates Acetic Acid-Induced Colitis in Rats Through Suppression of the Inflammatory Mediators. ( Abdolghaffari, AH; Abdollahi, AR; Baeeri, M; Dehpour, AR; Khayatan, D; Lashgari, NA; Momtaz, S; Roudsari, NM; Shahraki, FN, 2023) |
| "Macroscopic and microscopic assessments revealed that juglone significantly decreased colonic tissue damage and inflammation at 150 mg/kg." | 8.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "The current study was performed to evaluate the therapeutic impacts of the juglone in acetic acid-induced colitis in male Wistar rats." | 8.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| " Colitis was induced in 36 male Wistar rats (n = 6), except in the sham group, 1 ml of acetic acid 4% was administered intrarectally." | 8.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| " Juglone attenuated colitis symptoms, reduced inflammation cytokines, declined neutrophil infiltration, and suppressed IL- 1β and TNF-α expressions in acetic acid-induced colitis rats." | 8.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "All juglone-treated groups reduced the NF-κB levels compared to the control group (p < 0." | 5.91 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "Juglone is a phenolic bioactive compound with antimicrobial, antitumour, antioxidant, and anti-inflammatory characteristics." | 5.91 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "Juglone was extracted from Pterocarya fraxinifolia via maceration method." | 5.91 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "Colitis was induced in 36 male Wistar rats (n = 6), except in the sham group, 1 ml of acetic acid 4% was administered intrarectally." | 5.91 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "Colitis was induced by intrarectal administration of 6% AA in BALB/c mice." | 5.43 | Flaxseed extract exhibits mucosal protective effect in acetic acid induced colitis in mice by modulating cytokines, antioxidant and antiinflammatory mechanisms. ( Gilani, AH; Iqbal, NT; Minhas, K; Palla, AH, 2016) |
| "Ulcerative colitis is a disease that causes inflammation and ulcer in the lining of the large intestine." | 5.40 | Protective effect of marine mangrove Rhizophora apiculata on acetic acid induced experimental colitis by regulating anti-oxidant enzymes, inflammatory mediators and nuclear factor-kappa B subunits. ( C, G; V, VP, 2014) |
| "Colitis was induced by acetic acid (AA)." | 5.38 | Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats. ( Aygun, C; Bahcecioglu, IH; Demirel, U; Orhan, C; Ozercan, IH; Sahin, K; Tuzcu, M; Yalniz, M, 2012) |
| " The oral administration of HA-BUD-ES-NPs in an acetic acid induced colitis rat model significantly mitigated the symptoms of IBD, and improved BUD therapeutic efficacy compared to drug suspension." | 4.31 | Targeted delivery of budesonide in acetic acid induced colitis: impact on miR-21 and E-cadherin expression. ( Allam, EA; El-Kamel, AH; El-Moslemany, RM; Elkafrawy, H; Seoudi, SS, 2023) |
| " This study evaluated the anti-inflammatory effects of licofelone on acetic acid-induced colitis in rats." | 4.31 | Licofelone Attenuates Acetic Acid-Induced Colitis in Rats Through Suppression of the Inflammatory Mediators. ( Abdolghaffari, AH; Abdollahi, AR; Baeeri, M; Dehpour, AR; Khayatan, D; Lashgari, NA; Momtaz, S; Roudsari, NM; Shahraki, FN, 2023) |
| "Macroscopic and microscopic assessments revealed that juglone significantly decreased colonic tissue damage and inflammation at 150 mg/kg." | 4.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "The current study was performed to evaluate the therapeutic impacts of the juglone in acetic acid-induced colitis in male Wistar rats." | 4.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| " Colitis was induced in 36 male Wistar rats (n = 6), except in the sham group, 1 ml of acetic acid 4% was administered intrarectally." | 4.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| " Juglone attenuated colitis symptoms, reduced inflammation cytokines, declined neutrophil infiltration, and suppressed IL- 1β and TNF-α expressions in acetic acid-induced colitis rats." | 4.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "Juglone exhibited anti-inflammatory and antioxidant effects in the experimental colitis model and could be a therapeutic candidate for IBD." | 4.31 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "Colitis was induced by intra-rectal instillation of 1 ml acetic acid (4%)." | 3.96 | Biochemical and histopathological evidence for the beneficial effects of modafinil on the rat model of inflammatory bowel disease: involvement of nitric oxide pathway. ( Dehpour, AR; Dejban, P; Rahimi, N; Takzare, N, 2020) |
| " The objective of this experiment is to investigate the protective effects of modafinil on colitis induced by acetic acid in rat and the involvement of nitric oxide pathway." | 3.96 | Biochemical and histopathological evidence for the beneficial effects of modafinil on the rat model of inflammatory bowel disease: involvement of nitric oxide pathway. ( Dehpour, AR; Dejban, P; Rahimi, N; Takzare, N, 2020) |
| "While induction of colitis caused severe macroscopic lesions, administration of dexamethasone and modafinil (100 and 150 mg/kg) significantly improved macroscopic ulcers." | 3.96 | Biochemical and histopathological evidence for the beneficial effects of modafinil on the rat model of inflammatory bowel disease: involvement of nitric oxide pathway. ( Dehpour, AR; Dejban, P; Rahimi, N; Takzare, N, 2020) |
| " Support for the value of individual VOC quantification is illustrated by the SIFT-MS studies of breath hydrogen cyanide, HCN, a biomarker of Pseudomonas aeruginosa infection, breath acetic acid as an indicator of airways acidification in cystic fibrosis patients, and n-pentane as a breath biomarker of inflammation in idiopathic bowel disease patients." | 3.85 | On the importance of accurate quantification of individual volatile metabolites in exhaled breath. ( Smith, D; Španěl, P, 2017) |
| "CL improved body weight gain, mean macroscopic and microscopic ulcer scores in the colon of rats suffering from acetic acid-induced IBD." | 3.83 | Effect of turmeric on colon histology, body weight, ulcer, IL-23, MPO and glutathione in acetic-acid-induced inflammatory bowel disease in rats. ( Adeghate, E; Al Ahmed, MM; Al Zaabi, A; Amir, N; Bastaki, SMA, 2016) |
| " Subsequently, its protective effect in indomethacin and iodoacetamide induced colitis in rats (45, 90, 180, 270 mg/kg) and acetic acid induced colitis in mice (65, 130, 250, 500 mg/kg) was assessed." | 3.77 | Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice. ( Jagtap, AG; Niphadkar, PV; Phadke, AS, 2011) |
| " We measured PLA2 activity in the peritoneal leukocytes and eicosanoid content in the peritoneal cavity of rats with experimental colitis induced by dinitrochlorobenzene, immune complex-mediated colitis, and acetic acid-induced colitis." | 3.68 | Increased phospholipase A2 activity in peritoneal leukocytes in rat experimental colitis. ( Biondi, RJ; Murthy, SN, 1992) |
| "Juglone is a phenolic bioactive compound with antimicrobial, antitumour, antioxidant, and anti-inflammatory characteristics." | 1.91 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "All juglone-treated groups reduced the NF-κB levels compared to the control group (p < 0." | 1.91 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "Colitis was induced in 36 male Wistar rats (n = 6), except in the sham group, 1 ml of acetic acid 4% was administered intrarectally." | 1.91 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "Juglone was extracted from Pterocarya fraxinifolia via maceration method." | 1.91 | Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. ( Abdolghaffari, AH; Abdollahi, AR; Alizadeh Nobakht, NA; Esmaealzadeh, N; Khayatan, D; Lashgari, NA; Momeni Roudsari, N; Momtaz, S; Niknejad, A; Tavakoli, S, 2023) |
| "Ulcerative colitis (UC) and Crohn's disease (CD) are two major forms of inflammatory bowel disease (IBD)." | 1.91 | Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats. ( Gruneck, L; Phunikhom, K; Popluechai, S; Sattayasai, J; Sharpton, TJ; Thipart, K, 2023) |
| "Colitis was induced by intra-rectal instillation of 1 ml acetic acid (4%)." | 1.56 | Biochemical and histopathological evidence for the beneficial effects of modafinil on the rat model of inflammatory bowel disease: involvement of nitric oxide pathway. ( Dehpour, AR; Dejban, P; Rahimi, N; Takzare, N, 2020) |
| "Colitis was induced by intrarectal administration of 6% AA in BALB/c mice." | 1.43 | Flaxseed extract exhibits mucosal protective effect in acetic acid induced colitis in mice by modulating cytokines, antioxidant and antiinflammatory mechanisms. ( Gilani, AH; Iqbal, NT; Minhas, K; Palla, AH, 2016) |
| "Ulcerative colitis is a disease that causes inflammation and ulcer in the lining of the large intestine." | 1.40 | Protective effect of marine mangrove Rhizophora apiculata on acetic acid induced experimental colitis by regulating anti-oxidant enzymes, inflammatory mediators and nuclear factor-kappa B subunits. ( C, G; V, VP, 2014) |
| "Colitis was induced by acetic acid (AA)." | 1.38 | Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats. ( Aygun, C; Bahcecioglu, IH; Demirel, U; Orhan, C; Ozercan, IH; Sahin, K; Tuzcu, M; Yalniz, M, 2012) |
| "In Crohn's disease more than in ulcerative colitis, the aggregates had a predominant basal or transmural distribution." | 1.33 | Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases. ( Di Betta, E; Di Fabio, F; Fisogni, S; Mariani, P; Nascimbeni, R; Villanacci, V, 2005) |
| "A total of 77 patients (41 colorectal cancer, 27 diverticular disease, six ulcerative colitis, three Crohn's disease) undergoing colorectal resection were included." | 1.33 | Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases. ( Di Betta, E; Di Fabio, F; Fisogni, S; Mariani, P; Nascimbeni, R; Villanacci, V, 2005) |
| "Oral mucositis was induced in male Golden Syrian hamsters with 5-fluorouracil 60 mg/kg intraperitoneal, days 0 and 2." | 1.29 | IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. ( Albert, L; Keith, JC; Pfeiffer, CJ; Schaub, RG; Sonis, ST, 1994) |
| "Acetic acid treatment resulted in increased absorption on day 4, which return to control levels by day 14." | 1.29 | Exudative and absorptive permeability in different phases of an experimental colitis condition. ( McHugh, KJ; Persson, CG; Svensjö, E, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (24.24) | 18.2507 |
| 2000's | 4 (12.12) | 29.6817 |
| 2010's | 13 (39.39) | 24.3611 |
| 2020's | 8 (24.24) | 2.80 |
| Authors | Studies |
|---|---|
| Bastaki, SMA | 2 |
| Amir, N | 2 |
| Adeghate, E | 2 |
| Ojha, S | 1 |
| Savran, M | 1 |
| Ascı, H | 1 |
| Erzurumlu, Y | 1 |
| Ozmen, O | 1 |
| Ilhan, I | 1 |
| Sırın, MC | 1 |
| Karakuyu, NF | 1 |
| Karaibrahimoglu, A | 1 |
| Thipart, K | 2 |
| Gruneck, L | 2 |
| Phunikhom, K | 2 |
| Sharpton, TJ | 2 |
| Sattayasai, J | 2 |
| Popluechai, S | 2 |
| Seoudi, SS | 1 |
| Allam, EA | 1 |
| El-Kamel, AH | 2 |
| Elkafrawy, H | 1 |
| El-Moslemany, RM | 1 |
| Shahraki, FN | 1 |
| Momtaz, S | 2 |
| Baeeri, M | 1 |
| Khayatan, D | 2 |
| Lashgari, NA | 2 |
| Roudsari, NM | 1 |
| Abdollahi, AR | 2 |
| Dehpour, AR | 2 |
| Abdolghaffari, AH | 2 |
| Alizadeh Nobakht, NA | 1 |
| Momeni Roudsari, N | 1 |
| Niknejad, A | 1 |
| Tavakoli, S | 1 |
| Esmaealzadeh, N | 1 |
| Dejban, P | 1 |
| Rahimi, N | 1 |
| Takzare, N | 1 |
| Rath, B | 1 |
| Abul Qais, F | 1 |
| Patro, R | 1 |
| Mohapatra, S | 1 |
| Sharma, T | 1 |
| Smith, D | 1 |
| Španěl, P | 1 |
| Tang, QL | 1 |
| Lai, ML | 1 |
| Zhong, YF | 1 |
| Wang, AM | 1 |
| Su, JK | 1 |
| Zhang, MQ | 1 |
| V, VP | 1 |
| C, G | 1 |
| Kondamudi, PK | 1 |
| Kovelamudi, H | 1 |
| Mathew, G | 1 |
| Nayak, PG | 1 |
| Rao, MC | 1 |
| Shenoy, RR | 1 |
| Sareen, R | 1 |
| Jain, N | 1 |
| Rajkumari, A | 1 |
| Dhar, KL | 1 |
| Dodda, D | 1 |
| Chhajed, R | 1 |
| Mishra, J | 1 |
| Gopu, B | 1 |
| Dileep, R | 1 |
| Rani, MU | 1 |
| Kumar, CS | 1 |
| Kumar, MV | 1 |
| Reddy, AG | 1 |
| Al Ahmed, MM | 1 |
| Al Zaabi, A | 1 |
| Palla, AH | 1 |
| Iqbal, NT | 1 |
| Minhas, K | 1 |
| Gilani, AH | 1 |
| Jagtap, AG | 1 |
| Niphadkar, PV | 1 |
| Phadke, AS | 1 |
| Nakamura, N | 1 |
| Lin, HC | 1 |
| McSweeney, CS | 1 |
| Mackie, RI | 1 |
| Gaskins, HR | 1 |
| Yalniz, M | 1 |
| Demirel, U | 1 |
| Orhan, C | 1 |
| Bahcecioglu, IH | 1 |
| Ozercan, IH | 1 |
| Aygun, C | 1 |
| Tuzcu, M | 1 |
| Sahin, K | 1 |
| Yousef, M | 1 |
| Pichyangkura, R | 1 |
| Soodvilai, S | 1 |
| Chatsudthipong, V | 1 |
| Muanprasat, C | 1 |
| Singh, VP | 1 |
| Patil, CS | 1 |
| Jain, NK | 1 |
| Singh, A | 1 |
| Kulkarni, SK | 1 |
| Nascimbeni, R | 1 |
| Di Fabio, F | 1 |
| Di Betta, E | 1 |
| Mariani, P | 1 |
| Fisogni, S | 1 |
| Villanacci, V | 1 |
| Ghafari, H | 1 |
| Yasa, N | 1 |
| Mohammadirad, A | 1 |
| Dehghan, G | 1 |
| Zamani, MJ | 1 |
| Nikfar, S | 1 |
| Khorasani, R | 1 |
| Minaie, B | 1 |
| Abdollahi, M | 1 |
| Abdel-Aziz, AA | 1 |
| Fatani, AJ | 1 |
| El-Subbagh, HI | 1 |
| Wong, PY | 2 |
| Yue, G | 2 |
| Yin, K | 2 |
| Miyasaka, M | 2 |
| Lane, CL | 2 |
| Manning, AM | 2 |
| Anderson, DC | 2 |
| Sun, FF | 2 |
| Keith, JC | 1 |
| Albert, L | 1 |
| Sonis, ST | 1 |
| Pfeiffer, CJ | 1 |
| Schaub, RG | 1 |
| McHugh, KJ | 1 |
| Svensjö, E | 1 |
| Persson, CG | 1 |
| Gálvez, J | 1 |
| Makino, M | 1 |
| Inomata, Y | 1 |
| Ito, K | 1 |
| Tabata, K | 1 |
| Kim, YS | 1 |
| Son, M | 1 |
| Ko, JI | 1 |
| Cho, H | 1 |
| Yoo, M | 1 |
| Kim, WB | 1 |
| Song, IS | 1 |
| Kim, CY | 1 |
| Murthy, SN | 1 |
| Biondi, RJ | 1 |
1 review available for acetic acid and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Mechanisms of microbial hydrogen disposal in the human colon and implications for health and disease.
Topics: Acetic Acid; Colon; Colorectal Neoplasms; Humans; Hydrogen; Inflammatory Bowel Diseases; Methane; Me | 2010 |
32 other studies available for acetic acid and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Lycopodium Mitigates Oxidative Stress and Inflammation in the Colonic Mucosa of Acetic Acid-Induced Colitis in Rats.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Colitis; Colitis, Ulcerat | 2022 |
"Theranekron: A Novel Anti-inflammatory Candidate for Acetic Acid-Induced Colonic Inflammation in Rats".
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Colitis; Colon; Female; Inflammation; Inflammatory B | 2022 |
Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anthocyanins; Bacteria; Colitis, Ulcerative; Crohn Disease; Gastrointestinal M | 2023 |
Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anthocyanins; Bacteria; Colitis, Ulcerative; Crohn Disease; Gastrointestinal M | 2023 |
Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anthocyanins; Bacteria; Colitis, Ulcerative; Crohn Disease; Gastrointestinal M | 2023 |
Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anthocyanins; Bacteria; Colitis, Ulcerative; Crohn Disease; Gastrointestinal M | 2023 |
Targeted delivery of budesonide in acetic acid induced colitis: impact on miR-21 and E-cadherin expression.
Topics: Acetic Acid; Animals; Budesonide; Caco-2 Cells; Cadherins; Colitis; Humans; Hyaluronic Acid; Inflamm | 2023 |
Licofelone Attenuates Acetic Acid-Induced Colitis in Rats Through Suppression of the Inflammatory Mediators.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Colitis; Colitis, Ulcerative; Inflammation Mediators | 2023 |
Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Colitis; Colon; Inflammation; Inflamma | 2023 |
Biochemical and histopathological evidence for the beneficial effects of modafinil on the rat model of inflammatory bowel disease: involvement of nitric oxide pathway.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Colitis; Disease Models, Animal; Dose-Response Relat | 2020 |
Design, synthesis and molecular modeling studies of novel mesalamine linked coumarin for treatment of inflammatory bowel disease.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Disease Models, Animal; Do | 2021 |
On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
Topics: Acetic Acid; Biomarkers; Breath Tests; Cystic Fibrosis; Exhalation; Humans; Inflammatory Bowel Disea | 2017 |
Antinociceptive effect of berberine on visceral hypersensitivity in rats.
Topics: Acetic Acid; Analgesics; Animals; Berberine; Colon; Defecation; Disease Models, Animal; Disease Prog | 2013 |
Protective effect of marine mangrove Rhizophora apiculata on acetic acid induced experimental colitis by regulating anti-oxidant enzymes, inflammatory mediators and nuclear factor-kappa B subunits.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Cells, Cultured; Colitis; Colon; Cytok | 2014 |
Investigation of sesamol on myeloperoxidase and colon morphology in acetic acid-induced inflammatory bowel disorder in albino rats.
Topics: Acetic Acid; Animals; Benzodioxoles; Colon; Female; Inflammatory Bowel Diseases; Peroxidase; Phenols | 2014 |
pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chitosan; | 2016 |
Protective effect of quercetin against acetic acid induced inflammatory bowel disease (IBD) like symptoms in rats: possible morphological and biochemical alterations.
Topics: Acetic Acid; Animals; Colon; Glutathione; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Nit | 2014 |
Protective Role of Curcumin and Flunixin Against Acetic Acid-Induced Inflammatory Bowel Disease via Modulating Inflammatory Mediators and Cytokine Profile in Rats.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Clonixin; Colon; Curcumi | 2015 |
Effect of turmeric on colon histology, body weight, ulcer, IL-23, MPO and glutathione in acetic-acid-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Colitis, Ulcerative; Colo | 2016 |
Flaxseed extract exhibits mucosal protective effect in acetic acid induced colitis in mice by modulating cytokines, antioxidant and antiinflammatory mechanisms.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cell Movement; Colitis; Col | 2016 |
Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice.
Topics: Acetic Acid; Animals; Bombax; Colitis; Disease Models, Animal; Female; India; Indomethacin; Inflamma | 2011 |
Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats.
Topics: Acetic Acid; Animals; Colitis; Colon; Cyclooxygenase 2; Heme Oxygenase-1; Inflammatory Bowel Disease | 2012 |
Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Topics: Acetic Acid; Acute Disease; Administration, Oral; Animals; Anti-Inflammatory Agents; Apoptosis; Cell | 2012 |
Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Cyclooxygenase Inhibitors; Inf | 2003 |
Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Antigens, CD20; CD3 Complex; Colitis, Ulcerative; Color | 2005 |
Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity.
Topics: Acetic Acid; Animals; Indicators and Reagents; Inflammatory Bowel Diseases; Lipid Peroxidation; Mice | 2006 |
Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Buffers; Chromatograph | 2008 |
Antibodies to ICAM-1 ameliorate inflammation in acetic acid induced inflammatory bowel disease.
Topics: Acetates; Acetic Acid; Animals; Antibodies; Cell Adhesion Molecules; E-Selectin; Humans; Inflammator | 1995 |
Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease.
Topics: Acetates; Acetic Acid; Animals; Antibodies; Body Weight; Cell Movement; Inflammatory Bowel Diseases; | 1995 |
IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology.
Topics: Acetates; Acetic Acid; Animals; Animals, Genetically Modified; beta 2-Microglobulin; Colitis; Cricet | 1994 |
Exudative and absorptive permeability in different phases of an experimental colitis condition.
Topics: Acetic Acid; Animals; Cell Membrane Permeability; Chromium Radioisotopes; Colitis; Disease Models, A | 1996 |
Application of natural products in experimental models of intestinal inflammation in rats.
Topics: Acetic Acid; Alkaline Phosphatase; Animals; Biomarkers; Colitis; Disease Models, Animal; Humans; Inf | 1996 |
[Effect of plaunotol on trinitrobenzene sulfonic acid and acetic acid induced colonic lesions in rats].
Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Colon; Disease Models, Animal; Diterpenes; Dose-Response Re | 1998 |
Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease.
Topics: Acetic Acid; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents; Anti-Inflammatory Age | 1999 |
Increased phospholipase A2 activity in peritoneal leukocytes in rat experimental colitis.
Topics: Acetates; Acetic Acid; Animals; Arthus Reaction; Colitis; Dexamethasone; Dinitrochlorobenzene; Disea | 1992 |